This is a review about cdk9, based on 11 published articles, using cdk9 antibody in all methods. It is aimed to help Labome visitors find the most suited cdk9 antibody.
cdk9 synonym: C-2k; CDC2L4; CTK1; PITALRE; TAK; CDC2-related kinase; cell division cycle 2-like protein kinase 4; cell division protein kinase 9; serine/threonine protein kinase PITALRE; serine/threonine-protein kinase PITALRE; tat-associated kinase complex catalytic subunit

Santa Cruz BiotechnologySanta Cruz Biotechnology cdk9 product
  • ChIP assayIn 2011, Satoru Hashimoto et al. employed Santa Cruz Biotechnology cdk9 antibody to perform ChIP assay and western blot in order to show that immediate early gene expression is disrupted by MED23 mutation and results in intellectual disability [ncbi , more ]. In 2009, Moon Kyoo Jang et al. employed Santa Cruz Biotechnology cdk9 antibody to perform ChIP assays in order to study the association between the papillomavirus E2 proteins, the host Brd4 protein and the transcriptionally active cellular genes [ncbi , more ]. In 2008, Kelly J Perkins et al. employed Santa Cruz Biotechnology cdk9 antibody to demonstrate that a specific gene loop conformation is imposed on integrated HIV-1 provirus after transcriptional activation [ncbi , more ]. In 2005, Hans F Luecke et al. applied Santa Cruz Biotechnology cdk9 antibody to investigate the IL-8 and IkappaBalpha gene regulatory regions in A549 human lung carcinoma cells (catalog: sc-484) [ncbi , more ].
  • EMSAIn 2004, Annemieke A Michels et al. utilized Santa Cruz Biotechnology cdk9 antibody to study the association of core P-TEFb with HEXIM1 and 7SK RNA and the repression of kinase activity in human HeLa cells [ncbi , more ].
  • immunoprecipitationIn 2005, Manish Kumar et al. used Santa Cruz Biotechnology cdk9 antibody to study the importance of heat shock protein 40 for human immunodeficiency virus-1 Nef-mediated enhancement of viral gene expression and replication [ncbi , more ]. In 2004, Annemieke A Michels et al. utilized Santa Cruz Biotechnology cdk9 antibody to study the association of core P-TEFb with HEXIM1 and 7SK RNA and the repression of kinase activity in human HeLa cells [ncbi , more ]. In 2001, D K Lee et al. applied Santa Cruz Biotechnology cdk9 antibody to study the interaction between androgen receptor and the positive elongation factor P-TEFb [ncbi , more ].
  • western blotIn 2011, Satoru Hashimoto et al. employed Santa Cruz Biotechnology cdk9 antibody to perform ChIP assay and western blot in order to show that immediate early gene expression is disrupted by MED23 mutation and results in intellectual disability [ncbi , more ]. In 2009, Bo Huang et al. utilized Santa Cruz Biotechnology cdk9 antibody to introduce Brd4 as a coactivator of NF-kappa B via specific binding to acetylated RelA [ncbi , more ]. In 2008, Susan Nozell et al. utilized Santa Cruz Biotechnology cdk9 antibody to perform western blot in order to study the association between ING4 and the activity of NF-kappa B molecules bound with target gene promoters [ncbi , more ]. In 2005, Manish Kumar et al. used Santa Cruz Biotechnology cdk9 antibody to study the importance of heat shock protein 40 for human immunodeficiency virus-1 Nef-mediated enhancement of viral gene expression and replication [ncbi , more ]. In 2004, Annemieke A Michels et al. utilized Santa Cruz Biotechnology cdk9 antibody to study the association of core P-TEFb with HEXIM1 and 7SK RNA and the repression of kinase activity in human HeLa cells [ncbi , more ]. In 2003, Fan Zhang et al. utilized Santa Cruz Biotechnology cdk9 antibody to study transcriptional inhibition by P-TEFb (catalog: sc-13130) [ncbi , more ]. In 2001, D K Lee et al. applied Santa Cruz Biotechnology cdk9 antibody to study the interaction between androgen receptor and the positive elongation factor P-TEFb [ncbi , more ].
Meridian Life Science
  • western blotIn 2001, M Zhou et al. used Meridian Life Science cdk9 antibody to study CDK9 phosphorylation during human immunodeficiency virus type 1 transcription [ncbi , more ].
Articles Reviewed
  1. Satoru Hashimoto et al. (2011). "MED23 mutation links intellectual disability to dysregulation of immediate early gene expression".PMID 21868677
  2. Moon Kyoo Jang et al. (2009). "Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin".PMID 19129460
  3. Bo Huang et al. (2009). "Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA".PMID 19103749
  4. Susan Nozell et al. (2008). "The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes".PMID 18779315
  5. Kelly J Perkins et al. (2008). "Transcription-dependent gene looping of the HIV-1 provirus is dictated by recognition of pre-mRNA processing signals".PMID 18206969
  6. Manish Kumar et al. (2005). "Heat shock protein 40 is necessary for human immunodeficiency virus-1 Nef-mediated enhancement of viral gene expression and replication".PMID 16179353
  7. Hans F Luecke et al. (2005). "The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression".PMID 15879558
  8. Annemieke A Michels et al. (2004). "Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor".PMID 15201869
  9. Fan Zhang et al. (2003). "A model of repression: CTD analogs and PIE-1 inhibit transcriptional elongation by P-TEFb".PMID 12651893
  10. M Zhou et al. (2001). "TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription".PMID 11572868
  11. D K Lee et al. (2001). "Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation".PMID 11266437